Trial intelligence / Profile preview

ONO-1101 in patients scheduled for coronary angiography

jRCT2080220472Phase 2

Sponsor
Ono Pharmaceutical
Start
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of landiolol in coronary arteriosclerosis and arrhythmia, sponsored by Ono Pharmaceutical.

02

Drugs

landiolol
03

Conditions

coronary arteriosclerosisarrhythmia

Beyond the preview

Go deeper on jRCT2080220472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call